K083445

Substantially Equivalent

N ANTISERA TO HUMAN IMMUNOGLOBULINS (IGG, IGA AND IGM) AND N/T PROTEIN CONTROL LC

Applicant: Siemens Healthcare Diagnostics
Product code: CFN
Advisory panel: Immunology
Date received: 2008-11-21
Decision date: 2009-03-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Newark, DE, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.